Device Firms Want Their Own Guidelines On Risk Information In Ads
This article was originally published in The Gray Sheet
Executive Summary
FDA's draft guidance on presentation of risk information in advertisements fails to adequately distinguish between devices and drugs, according to device trade group AdvaMed